Your browser doesn't support javascript.
loading
Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis.
Norouzi, Somayye; Javinani, Ali; Aminorroaya, Arya; Masoumi, Maryam.
Affiliation
  • Norouzi S; Department of Internal Medicine, Qom University of Medical Sciences, Qom, Iran.
  • Javinani A; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Aminorroaya A; Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Masoumi M; Clinical Research Development Center, Shahid Beheshti Hospital, Qom University of Medical Sciences, Azadegan Sq., Shahid Beheshti Blvd, Qom, Iran. mmasoomi@muq.ac.ir.
BMC Cardiovasc Disord ; 20(1): 390, 2020 08 26.
Article in En | MEDLINE | ID: mdl-32847506
BACKGROUND: Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiographic parameters of systolic and diastolic dysfunction in such patients. METHODS: In this cross-sectional study, we evaluated patients with RA who were referred to our clinic from October 2017 to August 2018. After the exclusion of patients with concomitant CVD, all patients underwent transthoracic echocardiography and measurement of plasma autoantibodies. Moreover, possible confounders-including medications, CVD risk factors, Framingham risk score, disease activity score-28, duration of disease, simple disease activity index, and functional status-were assessed. RESULTS: We studied 135 patients with RA (mean age = 52.3 years; 111 (82.2%) females). We had missing data rates of up to 8.9% for some characteristics. E velocity was inversely correlated with rheumatoid factor (P = 0.009). Furthermore, the plasma levels of anti-citrullinated protein and anti-modified citrullinated vimentin (anti-MCV) antibodies were negatively correlated with left ventricular ejection fraction (LVEF) (P = 0.019 and P<0.001, respectively). After an adjustment for possible confounders, the linear regression model demonstrated that the anti-MCV level and the patient's age are significant predictors of LVEF. The receiver operating characteristic curve showed that anti-MCV antibody titer≥547.5 (IU/mL) signifies reduced LVEF (<50%) with a sensitivity of 85.7% and specificity of 93% (C-statistic = 0.843). CONCLUSIONS: Our findings showed a significant inverse correlation between anti-MCV antibody titer and LVEF. These results indicate that the application of anti-MCV is promising for the screening and early detection of cardiac systolic dysfunction. Future prospective studies will determine its role.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Stroke Volume / Vimentin / Ventricular Function, Left / Ventricular Dysfunction, Left / Anti-Citrullinated Protein Antibodies Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Cardiovasc Disord Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2020 Type: Article Affiliation country: Iran

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Stroke Volume / Vimentin / Ventricular Function, Left / Ventricular Dysfunction, Left / Anti-Citrullinated Protein Antibodies Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: BMC Cardiovasc Disord Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2020 Type: Article Affiliation country: Iran